SCA
ISEE

Signpost Capital Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Signpost Capital Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,587
Closed -$2.33M – 13
2016
Q3 		$2.33M Hold
50,587
– – 1.96% 11
2016
Q2 		$2.58M Hold
50,587
– – 1.36% 11
2016
Q1 		$2.14M Buy
50,587
+32,677
+182% +$1.66M 1% 18
2015
Q4 		$1.41M Buy
+17,910
New +$1.04M 0.38% 23

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Signpost Capital Advisors's ISEE Position: Q4 2016 in Review

Signpost Capital Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 50,587 shares — an estimated $2.33M sold.

Signpost Capital Advisors first reported a position in ISEE in Q4 2015 and held it in 4 quarters. The position peaked at $2.58M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Signpost Capital Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Signpost Capital Advisors sold 50,587 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $2.33M.
  • Signpost Capital Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • Signpost Capital Advisors's IVERIC bio, Inc. Common Stock position peaked at $2.58M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Signpost Capital Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.